Loading...
Header Logo
Keywords
Last Name
Institution

Dr Lawrence Geiter

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tupasi T, Gupta R, Danilovits M, Cirule A, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Gentry LM, Geiter LJ, Wells CD. Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis. Bull World Health Organ. 2016 Feb 01; 94(2):147-52. PMID: 26908964; PMCID: PMC4750433.
    2. Gupta R, Geiter LJ, Hafkin J, Wells CD. Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015 Oct; 19(10):1261-2. PMID: 26459547.
      View in: PubMed
    3. Gupta R, Geiter LJ, Wells CD, Gao M, Cirule A, Xiao H. Delamanid for Extensively Drug-Resistant Tuberculosis. N Engl J Med. 2015 Jul 16; 373(3):291-2. PMID: 26176402.
      View in: PubMed
    4. Wells CD, Gupta R, Hittel N, Geiter LJ. Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid. Eur Respir J. 2015 May; 45(5):1498-501. PMID: 25700385; PMCID: PMC4416109.
    5. Skripconoka V, Danilovits M, Pehme L, Tomson T, Skenders G, Kummik T, Cirule A, Leimane V, Kurve A, Levina K, Geiter LJ, Manissero D, Wells CD. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis. Eur Respir J. 2013 Jun; 41(6):1393-400. PMID: 23018916; PMCID: PMC3669462.
    6. Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012 Jun 07; 366(23):2151-60. PMID: 22670901.
      View in: PubMed
    7. Diacon AH, Dawson R, Hanekom M, Narunsky K, Venter A, Hittel N, Geiter LJ, Wells CD, Paccaly AJ, Donald PR. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis. 2011 Jul; 15(7):949-54. PMID: 21682970.
      View in: PubMed
    8. Moyo S, Hawkridge T, Mahomed H, Workman L, Minnies D, Geiter LJ, Verver S, Kibel M, Hussey GD. Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health. 2007 Mar; 43(3):178-83. PMID: 17316193.
      View in: PubMed
    9. Bock NN, Rogers T, Tapia JR, Herron GD, DeVoe B, Geiter LJ. Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates. Chest. 2001 Mar; 119(3):833-7. PMID: 11243965.
      View in: PubMed
    10. Daniel N, Lounis N, Ji B, O'Brien RJ, Vernon A, Geiter LJ, Szpytma M, Truffot-Pernot C, Hejblum G, Grosset J. Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens. Am J Respir Crit Care Med. 2000 May; 161(5):1572-7. PMID: 10806157.
      View in: PubMed
    11. Palmer CS, Miller B, Halpern MT, Geiter LJ. A model of the cost-effectiveness of directly observed therapy for treatment of tuberculosis. J Public Health Manag Pract. 1998 May; 4(3):1-13. PMID: 10186738.
      View in: PubMed
    12. Sumartojo EM, Geiter LJ, Miller B, Hale BE. Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health. 1997 Dec; 87(12):2008-11. PMID: 9431292; PMCID: PMC1381245.
    13. Villarino ME, Ridzon R, Weismuller PC, Elcock M, Maxwell RM, Meador J, Smith PJ, Carson ML, Geiter LJ. Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Respir Crit Care Med. 1997 May; 155(5):1735-8. PMID: 9154885.
      View in: PubMed
    14. Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ, Wahn U. [Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project]. Pneumologie. 1994 Oct; 48(10):761-4. PMID: 7808991.
      View in: PubMed
    15. Villarino ME, Geiter LJ, Schulte JM, Castro KG. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection. AIDS. 1994 Apr; 8(4):477-81. PMID: 8011250.
      View in: PubMed
    16. Jereb JA, Burwen DR, Dooley SW, Haas WH, Crawford JT, Geiter LJ, Edmond MB, Dowling JN, Shapiro R, Pasculle AW, et al. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis. 1993 Nov; 168(5):1219-24. PMID: 7901287.
      View in: PubMed
    17. Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993 Apr; 31(4):767-70. PMID: 8463384; PMCID: PMC263557.
    18. Villarino ME, Geiter LJ, Simone PM. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep. 1992 Nov-Dec; 107(6):616-25. PMID: 1454973; PMCID: PMC1403711.
    19. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, O'Brien RJ. Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis J. 1992 Jun; 11(6):450-6. PMID: 1608681.
      View in: PubMed
    20. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, Selin MJ, Good RC, O'Brien RJ. Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses. Am Rev Respir Dis. 1992 May; 145(5):1160-6. PMID: 1586061.
      View in: PubMed
    21. Geiter LJ. Contribution of pyrazinamide to antituberculosis chemotherapy. J Infect Dis. 1991 Sep; 164(3):610. PMID: 1869849.
      View in: PubMed
    22. O'Brien RJ, Geiter LJ, Lyle MA. Rifabutin (ansamycin LM427) for the treatment of pulmonary Mycobacterium avium complex. Am Rev Respir Dis. 1990 Apr; 141(4 Pt 1):821-6. PMID: 2158257.
      View in: PubMed
    23. Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med. 1990 Mar 15; 112(6):397-406. PMID: 2155569.
      View in: PubMed
    24. Geiter LJ, O'Brien RJ. From the Centers for Disease Control. Conference on new approaches for tuberculosis preventive therapy. J Infect Dis. 1987 Sep; 156(3):536-7. PMID: 3611841.
      View in: PubMed
    25. Geiter LJ, O'Brien RJ, Combs DL, Snider DE. United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide. Tubercle. 1987 Jun; 68(2 Suppl):41-6. PMID: 3318048.
      View in: PubMed
    26. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987 May; 135(5):1007-14. PMID: 3579001.
      View in: PubMed
    27. Geiter LJ, O'Brien RJ. Short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1987 May; 135(5):1215. PMID: 3555197.
      View in: PubMed
    Geiter's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description